Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,992.28
(
1.03%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.38
(
2.11%
)
Bitcoin
74,300.01
(
-0.73%
)
News Focus
News Focus

Replies to post #295953 on NorthWest Biotherapeutics Inc (NWBO)

Replies to #295953 on NorthWest Biotherapeutics Inc (NWBO)
icon url

Gus1212

07/22/20 4:48 PM

#295957 RE: reachjo #295953

Very Interesting - Im all for it !

Let's roll


icon url

JTORENCE

07/22/20 4:51 PM

#295958 RE: reachjo #295953

reachjo agree completely. Been say this for months. To many advantages not to merge. Cuts a lot of the red tape ..imo
icon url

inclinedampforest

07/22/20 5:00 PM

#295961 RE: reachjo #295953

" Reach Jo"... Addirional point...

In that scenario , in whose best interest would it be to keep the price of NWBO at 35 at this time ? It would certainly invite investigation.
icon url

Hspooner

07/22/20 5:02 PM

#295962 RE: reachjo #295953

Great analysis Reachjo I think you're on to something, when you add up what Linda Powers has put together, Advent bioservices, Cognant bioservices, Inmune Bio, and NW bio one big happy family. We could be looking at a baby Genentech!!
icon url

Doc logic

07/22/20 5:07 PM

#295963 RE: reachjo #295953

reachjo,

Glad to see another big picture poster getting some attention. Maybe others will start to see it too. NWBO has lots of connections and news to report at the right time. Best wishes.
icon url

exwannabe

07/22/20 5:11 PM

#295964 RE: reachjo #295953

INmune has only 7 employees and zero capability of production at this point.


LMAO.

You do understand that they use Advent for manufacturing.
icon url

antihama

07/22/20 5:17 PM

#295965 RE: reachjo #295953

Assuming DCVax-L is successful than I would object if NWBO is not valued appropriately if they ever considered a merger. It may or may not take a little time for that to happen. And even if NWBO was valued appropriately where the market knows it has a paradigm shifting drug I would still think it's a bad idea because Alzheimer's is not in NWBO's wheelhouse. NWBO would need to focus on most solid tumors out there both operable (DCVax-L) and inoperable (Direct). They need to be totally focused on that. I think it's a totally bad idea and the most likely outcome would be that NWBO investors would be robbed of a great opportunity; that's assuming the DCVax-L trial is successful. I just had to put my 2 cents out there.
icon url

monentum2play

07/22/20 5:58 PM

#295976 RE: reachjo #295953

That would be a reason to keep the price down on Nwbo.
icon url

tryn2

07/22/20 9:17 PM

#296002 RE: reachjo #295953

Any merger BETTER occur AFTER DCVAX-L is approved and D is included in the valuation or I’m getting a lawyer... l haven’t faithfully held a penny stock for 5 years waiting on the payoff and to have it on the cusp of TLD (and appropriate valuation), only to merge with a 35 cent value. Not gonna happen.... nope.